{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:31:16Z","timestamp":1789986676318,"version":"4.0.1"},"reference-count":250,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:00:00Z","timestamp":1486080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:00:00Z","timestamp":1486080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS048837"],"award-info":[{"award-number":["NS048837"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS070896"],"award-info":[{"award-number":["NS070896"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s11481-016-9724-3","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T08:41:07Z","timestamp":1486111267000},"page":"51-83","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery"],"prefix":"10.1007","volume":"12","author":[{"given":"Chaitanya R.","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Labhasetwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuja","family":"Ghorpade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,3]]},"reference":[{"key":"9724_CR1","doi-asserted-by":"publisher","first-page":"e12387","DOI":"10.1371\/journal.pone.0012387","volume":"5","author":"WM Aartsen","year":"2010","unstructured":"Aartsen WM, Van Cleef KW, Pellissier LP, Hoek RM, Vos RM, Blits B, Ehlert EM, Balaggan KS, Ali RR, Verhaagen J (2010) GFAP-driven GFP expression in activated mouse M\u00fcller glial cells aligning retinal blood vessels following intravitreal injection of AAV2\/6 vectors. PloS One 5:e12387","journal-title":"PloS One"},{"key":"9724_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott NJ, R\u00f6nnb\u00e4ck L, Hansson E (2006) Astrocyte\u2013endothelial interactions at the blood\u2013brain barrier. Nature Reviews. Neuroscience 7:41\u201353","journal-title":"Nature Reviews. Neuroscience"},{"key":"9724_CR3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1089\/hum.2005.16.741","volume":"16","author":"E Abordo-Adesida","year":"2005","unstructured":"Abordo-Adesida E, Follenzi A, Barcia C, Sciascia S, Castro MG, Naldini L, Lowenstein PR (2005) Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses. Human Gene Therapy 16:741\u2013751","journal-title":"Human Gene Therapy"},{"key":"9724_CR4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/j.1750-3639.2012.00592.x","volume":"22","author":"SA Adam","year":"2012","unstructured":"Adam SA, Schnell O, P\u00f6schl J, Eigenbrod S, Kretzschmar HA, Tonn JC, Sch\u00fcller U (2012) ALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients. Brain Pathology 22:788\u2013797","journal-title":"Brain Pathology"},{"key":"9724_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1126\/science.1227901","volume":"339","author":"A Aguzzi","year":"2013","unstructured":"Aguzzi A, Barres BA, Bennett ML (2013) Microglia: scapegoat, saboteur, or something else? Science 339:156\u2013161","journal-title":"Science"},{"key":"9724_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ijpharm.2015.05.043","volume":"490","author":"H Akita","year":"2015","unstructured":"Akita H, Nakatani T, Kuroki K, Maenaka K, Tange K, Nakai Y, Harashima H (2015) Effect of hydrophobic scaffold on the cellular uptake and gene transfection activities of DNA-encapsulating liposomal nanoparticles via intracerebroventricular administration. International Journal of Pharmaceutics 490:142\u2013145","journal-title":"International Journal of Pharmaceutics"},{"key":"9724_CR7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/acel.12054","volume":"12","author":"E Alberdi","year":"2013","unstructured":"Alberdi E, Wyssenbach A, Alberdi M, Sanchez-Gomez MV, Cavaliere F, Rodriguez JJ, Verkhratsky A, Matute C (2013) Ca(2+) -dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid beta-treated astrocytes and in a model of Alzheimer\u2019s disease. Aging Cell 12:292\u2013302","journal-title":"Aging Cell"},{"key":"9724_CR8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/457675a","volume":"457","author":"NJ Allen","year":"2009","unstructured":"Allen NJ, Barres BA (2009) Neuroscience: glia\u2014more than just brain glue. Nature 457:675\u2013677","journal-title":"Nature"},{"key":"9724_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.pharmthera.2013.01.004","volume":"138","author":"SJ Allen","year":"2013","unstructured":"Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK (2013) GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacology & Therapeutics 138:155\u2013175","journal-title":"Pharmacology & Therapeutics"},{"key":"9724_CR10","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00702-013-1149-z","volume":"121","author":"G Ambrosi","year":"2014","unstructured":"Ambrosi G, Cerri S, Blandini F (2014) A further update on the role of excitotoxicity in the pathogenesis of Parkinson\u2019s disease. Journal of Neural Transmission 121:849\u2013859","journal-title":"Journal of Neural Transmission"},{"key":"9724_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/(SICI)1097-4547(19990301)55:5<569::AID-JNR4>3.0.CO;2-F","volume":"55","author":"E Ambrosini","year":"1999","unstructured":"Ambrosini E, Ceccherini-Silberstein F, Erfle V, Aloisi F, Levi G (1999) Gene transfer in astrocytes: comparison between different delivering methods and expression of the HIV-1 protein Nef. Journal of Neuroscience Research 55:569\u2013577","journal-title":"Journal of Neuroscience Research"},{"key":"9724_CR12","first-page":"48","volume":"25","author":"H An","year":"2016","unstructured":"An H, Cho D-W, Lee SE, Yang Y-S, Han S-C, Lee CJ (2016) Differential cellular tropism of lentivirus and adeno-associated virus in the brain of Cynomolgus monkey. Experimental Neurology 25:48\u201354","journal-title":"Experimental Neurology"},{"key":"9724_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nature17623","volume":"532","author":"MA Anderson","year":"2016","unstructured":"Anderson MA, Burda JE, Ren Y, Ao Y, O\u2019Shea TM, Kawaguchi R, Coppola G, Khakh BS, Deming TJ, Sofroniew MV (2016) Astrocyte scar formation aids central nervous system axon regeneration. Nature 532:195\u2013200","journal-title":"Nature"},{"key":"9724_CR14","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1093\/brain\/awt273","volume":"136","author":"CH Andrade-Moraes","year":"2013","unstructured":"Andrade-Moraes CH, Oliveira-Pinto AV, Castro-Fonseca E, da Silva CG, Guimar\u00e3es DM, Szczupak D, Parente-Bruno DR, Carvalho LR, Polichiso L, Gomes BV (2013) Cell number changes in Alzheimer\u2019s disease relate to dementia, not to plaques and tangles. Brain 136:3738\u20133752","journal-title":"Brain"},{"key":"9724_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1006\/mthe.2001.0264","volume":"3","author":"JL Andrews","year":"2001","unstructured":"Andrews JL, Kadan MJ, Gorziglia MI, Kaleko M, Connelly S (2001) Generation and characterization of E1\/E2a\/E3\/E4-deficient adenoviral vectors encoding human factor VIII. Molecular Therapy 3:329","journal-title":"Molecular Therapy"},{"key":"9724_CR16","first-page":"25","volume":"12","author":"P Anglade","year":"1997","unstructured":"Anglade P, Vyas S, Javoy-Agid F, Herrero M, Michel P, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch E, Agid Y (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson\u2019s disease. Histology and Histopathology 12:25\u201332","journal-title":"Histology and Histopathology"},{"key":"9724_CR17","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/mds.26020","volume":"29","author":"N Aronin","year":"2014","unstructured":"Aronin N, DiFiglia M (2014) Huntingtin-lowering strategies in Huntington\u2019s disease: antisense oligonucleotides, small RNAs, and gene editing. Movement Disorders 29:1455\u20131461","journal-title":"Movement Disorders"},{"key":"9724_CR18","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s10571-011-9725-y","volume":"31","author":"L Arregui","year":"2011","unstructured":"Arregui L, Ben\u00edtez JA, Razgado LF, Vergara P, Segovia J (2011) Adenoviral astrocyte-specific expression of BDNF in the striata of mice transgenic for Huntington\u2019s disease delays the onset of the motor phenotype. Cellular and Molecular Neurobiology 31:1229\u20131243","journal-title":"Cellular and Molecular Neurobiology"},{"key":"9724_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0143-4160(03)00141-6","volume":"34","author":"M Arundine","year":"2003","unstructured":"Arundine M, Tymianski M (2003) Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 34:325\u2013337","journal-title":"Cell Calcium"},{"key":"9724_CR20","doi-asserted-by":"publisher","first-page":"e76310","DOI":"10.1371\/journal.pone.0076310","volume":"8","author":"DF Aschauer","year":"2013","unstructured":"Aschauer DF, Kreuz S, Rumpel S (2013) Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain. PloS One 8:e76310","journal-title":"PloS One"},{"key":"9724_CR21","doi-asserted-by":"publisher","first-page":"e332","DOI":"10.1038\/cddis.2012.54","volume":"3","author":"CC Ashutosh","year":"2012","unstructured":"Ashutosh CC, Borgmann K, Brew K, Ghorpade A (2012) Tissue inhibitor of metalloproteinases-1 protects human neurons from staurosporine and HIV-1-induced apoptosis: mechanisms and relevance to HIV-1-associated dementia. Cell Death & Disease 3:e332","journal-title":"Cell Death & Disease"},{"key":"9724_CR22","unstructured":"AveXis I (2016) AveXis reports data from ongoing phase 1 trial of AVXS-101 in spinal muscular atrophy type 1. In: AxeVis Inc."},{"key":"9724_CR23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.neuron.2008.10.013","volume":"60","author":"BA Barres","year":"2008","unstructured":"Barres BA (2008) The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 60:430\u2013440","journal-title":"Neuron"},{"key":"9724_CR24","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1089\/hum.1998.9.8-1181","volume":"9","author":"JS Bartlett","year":"1998","unstructured":"Bartlett JS, Samulski RJ, McCown TJ (1998) Selective and rapid uptake of adeno-associated virus type 2 in brain. Human Gene Therapy 9:1181\u20131186","journal-title":"Human Gene Therapy"},{"key":"9724_CR25","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/mt.2013.281","volume":"22","author":"RT Bartus","year":"2014","unstructured":"Bartus RT, Weinberg MS, Samulski RJ (2014) Parkinson\u2019s disease gene therapy: success by design meets failure by efficacy. Molecular Therapy 22:487\u2013497","journal-title":"Molecular Therapy"},{"key":"9724_CR26","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.bbi.2010.12.008","volume":"25","author":"DR Beers","year":"2011","unstructured":"Beers DR, Zhao W, Liao B, Kano O, Wang J, Huang A, Appel SH, Henkel JS (2011) Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice. Brain, Behavior, and Immunity 25:1025\u20131035","journal-title":"Brain, Behavior, and Immunity"},{"key":"9724_CR27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1124\/jpet.108.137455","volume":"326","author":"AN Begum","year":"2008","unstructured":"Begum AN, Jones MR, Lim GP, Morihara T, Kim P, Heath DD, Rock CL, Pruitt MA, Yang F, Hudspeth B (2008) Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer\u2019s disease. The Journal of Pharmacology and Experimental Therapeutics 326:196\u2013208","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"9724_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-8-21","volume":"8","author":"MJ Bellini","year":"2011","unstructured":"Bellini MJ, Here\u00f1\u00fa CB, Goya RG, Garcia-Segura LM (2011) Insulin-like growth factor-I gene delivery to astrocytes reduces their inflammatory response to lipopolysaccharide. Journal of Neuroinflammation 8:1","journal-title":"Journal of Neuroinflammation"},{"key":"9724_CR29","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1089\/10430349950016393","volume":"10","author":"A-P Bemelmans","year":"1999","unstructured":"Bemelmans A-P, Horellou P, Pradier L, Brunet I, Colin P, Mallet J (1999) Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington\u2019s disease, as demonstrated by adenoviral gene transfer. Human Gene Therapy 10:2987\u20132997","journal-title":"Human Gene Therapy"},{"key":"9724_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/mt.2012.261","volume":"21","author":"S Benkhelifa-Ziyyat","year":"2013","unstructured":"Benkhelifa-Ziyyat S, Besse A, Roda M, Duque S, Astord S, Carcenac R, Marais T, Barkats M (2013) Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice. Molecular Therapy 21:282\u2013290","journal-title":"Molecular Therapy"},{"key":"9724_CR31","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.nbd.2007.03.006","volume":"26","author":"L Benvenisti-Zarom","year":"2007","unstructured":"Benvenisti-Zarom L, Regan RF (2007) Astrocyte-specific heme oxygenase-1 hyperexpression attenuates heme-mediated oxidative injury. Neurobiology of Disease 26:688\u2013695","journal-title":"Neurobiology of Disease"},{"key":"9724_CR32","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/mt.2011.157","volume":"19","author":"AK Bevan","year":"2011","unstructured":"Bevan AK, Duque S, Foust KD, Morales PR, Braun L, Schmelzer L, Chan CM, McCrate M, Chicoine LG, Coley BD (2011) Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders. Molecular Therapy 19:1971\u20131980","journal-title":"Molecular Therapy"},{"key":"9724_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong J-S (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nature Reviews. Neuroscience 8:57\u201369","journal-title":"Nature Reviews. Neuroscience"},{"key":"9724_CR34","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/hmg\/5.Supplement_1.1397","volume":"5","author":"U Bl\u00f6mer","year":"1996","unstructured":"Bl\u00f6mer U, Naldini L, Verma IM, Trono D, Gage FH (1996) Applications of gene therapy to the CNS. Human Molecular Genetics 5:1397\u20131404","journal-title":"Human Molecular Genetics"},{"key":"9724_CR35","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1128\/jvi.71.9.6641-6649.1997","volume":"71","author":"U Bl\u00f6mer","year":"1997","unstructured":"Bl\u00f6mer U, Naldini L, Kafri T, Trono D, Verma IM, Gage FH (1997) Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. Journal of Virology 71:6641\u20136649","journal-title":"Journal of Virology"},{"key":"9724_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neuron.2006.09.018","volume":"52","author":"S Boill\u00e9e","year":"2006","unstructured":"Boill\u00e9e S, Velde CV, Cleveland DW (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52:39\u201359","journal-title":"Neuron"},{"key":"9724_CR37","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1089\/hum.2009.182","volume":"21","author":"S Boutin","year":"2010","unstructured":"Boutin S, Monteilhet V, Veron P, Leborgne C, Benveniste O, Montus MF, Masurier C (2010) Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors. Human Gene Therapy 21:704\u2013712","journal-title":"Human Gene Therapy"},{"key":"9724_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-009-0601-5","volume":"119","author":"M Bradl","year":"2010","unstructured":"Bradl M, Lassmann H (2010) Oligodendrocytes: biology and pathology. Acta Neuropathologica 119:37\u201353","journal-title":"Acta Neuropathologica"},{"key":"9724_CR39","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1523\/JNEUROSCI.14-03-01030.1994","volume":"14","author":"M Brenner","year":"1994","unstructured":"Brenner M, Kisseberth WC, Su Y, Besnard F, Messing A (1994) GFAP promoter directs astrocyte-specific expression in transgenic mice. The Journal of Neuroscience 14:1030\u20131037","journal-title":"The Journal of Neuroscience"},{"key":"9724_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bcp.2009.09.014","volume":"79","author":"A Buffo","year":"2010","unstructured":"Buffo A, Rolando C, Ceruti S (2010) Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential. Biochemical Pharmacology 79:77\u201389","journal-title":"Biochemical Pharmacology"},{"key":"9724_CR41","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1523\/JNEUROSCI.16-09-03045.1996","volume":"16","author":"AP Byrnes","year":"1996","unstructured":"Byrnes AP, MacLaren RE, Charlton HM (1996) Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination. The Journal of Neuroscience 16:3045\u20133055","journal-title":"The Journal of Neuroscience"},{"key":"9724_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2174\/1573406411666151019120444","volume":"12","author":"R Cabezas","year":"2016","unstructured":"Cabezas R, Avila-Rodriguez M, Vega-Vela NE, Echeverria V, Gonz\u00e1lez J, Hidalgo OA, Santos AB, Aliev G, Barreto GE (2016) Growth factors and astrocytes metabolism: possible roles for platelet derived growth factor. Medicinal Chemistry 12:204\u2013210","journal-title":"Medicinal Chemistry"},{"key":"9724_CR43","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.tins.2005.01.007","volume":"28","author":"EM Callaway","year":"2005","unstructured":"Callaway EM (2005) A molecular and genetic arsenal for systems neuroscience. Trends in Neurosciences 28:196\u2013201","journal-title":"Trends in Neurosciences"},{"key":"9724_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.expneurol.2010.10.016","volume":"228","author":"JR Cannon","year":"2011","unstructured":"Cannon JR, Sew T, Montero L, Burton EA, Greenamyre JT (2011) Pseudotype-dependent lentiviral transduction of astrocytes or neurons in the rat substantia nigra. Experimental Neurology 228:41\u201352","journal-title":"Experimental Neurology"},{"key":"9724_CR45","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cnr.2006.09.004","volume":"6","author":"MJ Carson","year":"2006","unstructured":"Carson MJ, Thrash JC, Walter B (2006) The cellular response in neuroinflammation: the role of leukocytes, microglia and astrocytes in neuronal death and survival. Clinical Neuroscience Research 6:237\u2013245","journal-title":"Clinical Neuroscience Research"},{"key":"9724_CR46","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/mt.2008.166","volume":"16","author":"CN Cearley","year":"2008","unstructured":"Cearley CN, Vandenberghe LH, Parente MK, Carnish ER, Wilson JM, Wolfe JH (2008) Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain. Molecular Therapy 16:1710\u20131718","journal-title":"Molecular Therapy"},{"key":"9724_CR47","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1158\/0008-5472.CAN-09-3567","volume":"70","author":"V Cerullo","year":"2010","unstructured":"Cerullo V, Pesonen S, Diaconu I, Escutenaire S, Arstila PT, Ugolini M, Nokisalmi P, Raki M, Laasonen L, S\u00e4rkioja M (2010) Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients. Cancer Research 70:4297\u20134309","journal-title":"Cancer Research"},{"key":"9724_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-7-74","volume":"7","author":"A-G Ceulemans","year":"2010","unstructured":"Ceulemans A-G, Zgavc T, Kooijman R, Hachimi-Idrissi S, Sarre S, Michotte Y (2010) The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. Journal of Neuroinflammation 7:1","journal-title":"Journal of Neuroinflammation"},{"key":"9724_CR49","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2147\/IJN.S54750","volume":"9","author":"M Chaturvedi","year":"2014","unstructured":"Chaturvedi M, Molino Y, Sreedhar B, Khrestchatisky M, Kaczmarek L (2014) Tissue inhibitor of matrix metalloproteinases-1 loaded poly (lactic-co-glycolic acid) nanoparticles for delivery across the blood\u2013brain barrier. International Journal of Nanomedicine 9:575","journal-title":"International Journal of Nanomedicine"},{"key":"9724_CR50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/sj.gt.3300547","volume":"5","author":"H Chen","year":"1998","unstructured":"Chen H, McCarty D, Bruce A, Suzuki K (1998) Gene transfer and expression in oligodendrocytes under the control of myelin basic protein transcriptional control region mediated by adeno-associated virus. Gene Therapy 5:50\u201358","journal-title":"Gene Therapy"},{"key":"9724_CR51","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/sc.2011.138","volume":"50","author":"X Chen","year":"2012","unstructured":"Chen X, Lin W, Lin J, Wu C, Zhang L, Huang Z, Lai J (2012) The protective effects of the lentivirus-mediated neuroglobin gene transfer on spinal cord injury in rabbits. Spinal Cord 50:467\u2013471","journal-title":"Spinal Cord"},{"key":"9724_CR52","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1126\/science.275.5301.838","volume":"275","author":"DL Choi-Lundberg","year":"1997","unstructured":"Choi-Lundberg DL, Lin Q, Chang Y-N, Chiang YL, Hay CM, Mohajeri H, Davidson BL, Bohn MC (1997) Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275:838\u2013841","journal-title":"Science"},{"key":"9724_CR53","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/mt.2012.167","volume":"21","author":"A Ciesielska","year":"2013","unstructured":"Ciesielska A, Hadaczek P, Mittermeyer G, Zhou S, Wright JF, Bankiewicz KS, Forsayeth J (2013) Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responses. Molecular Therapy 21:158\u2013166","journal-title":"Molecular Therapy"},{"key":"9724_CR54","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2174\/157016212802138832","volume":"10","author":"IE Cisneros","year":"2012","unstructured":"Cisneros IE, Ghorpade A (2012) HIV-1, methamphetamine and astrocyte glutamate regulation: combined excitotoxic implications for neuro-AIDS. Current HIV Research 10:392\u2013406","journal-title":"Current HIV Research"},{"key":"9724_CR55","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.neuropharm.2014.06.011","volume":"85","author":"IE Cisneros","year":"2014","unstructured":"Cisneros IE, Ghorpade A (2014) Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytes. Neuropharmacology 85:499\u2013507","journal-title":"Neuropharmacology"},{"key":"9724_CR56","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neulet.2014.01.014","volume":"565","author":"AM Colangelo","year":"2014","unstructured":"Colangelo AM, Alberghina L, Papa M (2014) Astrogliosis as a therapeutic target for neurodegenerative diseases. Neuroscience Letters 565:59\u201364","journal-title":"Neuroscience Letters"},{"key":"9724_CR57","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/glia.20795","volume":"57","author":"A Colin","year":"2009","unstructured":"Colin A, Faideau M, Dufour N, Auregan G, Hassig R, Andrieu T, Brouillet E, Hantraye P, Bonvento G, D\u00e9glon N (2009) Engineered lentiviral vector targeting astrocytes in vivo. Glia 57:667\u2013679","journal-title":"Glia"},{"key":"9724_CR58","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/sj.gt.3301925","volume":"10","author":"M Cucchiarini","year":"2003","unstructured":"Cucchiarini M, Ren X, Perides G, Terwilliger E (2003) Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectors. Gene Therapy 10:657\u2013667","journal-title":"Gene Therapy"},{"key":"9724_CR59","doi-asserted-by":"publisher","first-page":"s283","DOI":"10.1007\/s10072-003-0175-2","volume":"24","author":"N De Stefano","year":"2003","unstructured":"De Stefano N, Guidi L, Stromillo M, Bartolozzi M, Federico A (2003) Imaging neuronal and axonal degeneration in multiple sclerosis. Neurological Sciences 24:s283\u2013s286","journal-title":"Neurological Sciences"},{"key":"9724_CR60","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1586\/ern.09.99","volume":"9","author":"W Debinski","year":"2009","unstructured":"Debinski W, Tatter SB (2009) Convection-enhanced delivery for the treatment of brain tumors. Expert Review of Neurotherapeutics 9:1519\u20131527","journal-title":"Expert Review of Neurotherapeutics"},{"key":"9724_CR61","doi-asserted-by":"publisher","first-page":"e6227","DOI":"10.1371\/journal.pone.0006227","volume":"4","author":"M Desclaux","year":"2009","unstructured":"Desclaux M, Teigell M, Amar L, Vogel R, y Ribotta MG, Privat A, Mallet J (2009) A novel and efficient gene transfer strategy reduces glial reactivity and improves neuronal survival and axonal growth in vitro. PloS One 4:e6227","journal-title":"PloS One"},{"key":"9724_CR62","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/jnr.20787","volume":"83","author":"A Dhar","year":"2006","unstructured":"Dhar A, Gardner J, Borgmann K, Wu L, Ghorpade A (2006) Novel role of TGF-beta in differential astrocyte-TIMP-1 regulation: implications for HIV-1-dementia and neuroinflammation. Journal of Neuroscience Research 83:1271\u20131280","journal-title":"Journal of Neuroscience Research"},{"key":"9724_CR63","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel J, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990\u20131993","journal-title":"Science"},{"key":"9724_CR64","doi-asserted-by":"publisher","first-page":"18206","DOI":"10.1073\/pnas.0407976101","volume":"101","author":"T Dittgen","year":"2004","unstructured":"Dittgen T, Nimmerjahn A, Komai S, Licznerski P, Waters J, Margrie TW, Helmchen F, Denk W, Brecht M, Osten P (2004) Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo. Proceedings of the National Academy of Sciences 101:18206\u201318211","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"9724_CR65","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/sj.gt.3302222","volume":"11","author":"N Do Thi","year":"2004","unstructured":"Do Thi N, Saillour P, Ferrero L, Dedieu J, Mallet J, Paunio T (2004) Delivery of GDNF by an E1, E3\/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson\u2019s disease. Gene Therapy 11:746\u2013756","journal-title":"Gene Therapy"},{"key":"9724_CR66","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1089\/hum.1996.7.17-2101","volume":"7","author":"J-Y Dong","year":"1996","unstructured":"Dong J-Y, Fan P-D, Frizzell RA (1996) Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Human Gene Therapy 7:2101\u20132112","journal-title":"Human Gene Therapy"},{"key":"9724_CR67","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/gt.2016.6","volume":"23","author":"A Donsante","year":"2016","unstructured":"Donsante A, McEachin Z, Riley J, Leung C, Kanz L, O\u2019Connor D, Boulis N (2016) Intracerebroventricular delivery of self-complementary adeno-associated virus serotype 9 to the adult rat brain. Gene Therapy 23:401\u2013407","journal-title":"Gene Therapy"},{"key":"9724_CR68","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.biotechadv.2008.10.003","volume":"27","author":"E Dormond","year":"2009","unstructured":"Dormond E, Perrier M, Kamen A (2009) From the first to the third generation adenoviral vector: what parameters are governing the production yield? Biotechnology Advances 27:133\u2013144","journal-title":"Biotechnology Advances"},{"key":"9724_CR69","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/mt.2011.249","volume":"20","author":"A Drinkut","year":"2012","unstructured":"Drinkut A, Tereshchenko Y, Schulz JB, B\u00e4hr M, K\u00fcgler S (2012) Efficient gene therapy for Parkinson\u2019s disease using astrocytes as hosts for localized neurotrophic factor delivery. Molecular Therapy 20:534\u2013543","journal-title":"Molecular Therapy"},{"key":"9724_CR70","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1212\/01.wnl.0000312381.29287.ff","volume":"70","author":"J Eberling","year":"2008","unstructured":"Eberling J, Jagust W, Christine C, Starr P, Larson P, Bankiewicz K, Aminoff M (2008) Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology 70:1980\u20131983","journal-title":"Neurology"},{"key":"9724_CR71","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.biopha.2003.11.004","volume":"58","author":"J Emerit","year":"2004","unstructured":"Emerit J, Edeas M, Bricaire F (2004) Neurodegenerative diseases and oxidative stress. Biomedicine & Pharmacotherapy 58:39\u201346","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"9724_CR72","doi-asserted-by":"publisher","first-page":"5978","DOI":"10.1523\/JNEUROSCI.0302-06.2006","volume":"26","author":"C Escartin","year":"2006","unstructured":"Escartin C, Brouillet E, Gubellini P, Trioulier Y, Jacquard C, Smadja C, Knott GW, Kerkerian-Le Goff L, D\u00e9glon N, Hantraye P (2006) Ciliary neurotrophic factor activates astrocytes, redistributes their glutamate transporters GLAST and GLT-1 to raft microdomains, and improves glutamate handling in vivo. The Journal of Neuroscience 26:5978\u20135989","journal-title":"The Journal of Neuroscience"},{"key":"9724_CR73","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mcn.2012.10.008","volume":"53","author":"MC Evans","year":"2013","unstructured":"Evans MC, Couch Y, Sibson N, Turner MR (2013) Inflammation and neurovascular changes in amyotrophic lateral sclerosis. Molecular and Cellular Neurosciences 53:34\u201341","journal-title":"Molecular and Cellular Neurosciences"},{"key":"9724_CR74","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.nbd.2009.11.018","volume":"37","author":"ALDL Ezcurra","year":"2010","unstructured":"Ezcurra ALDL, Chertoff M, Ferrari C, Graciarena M, Pitossi F (2010) Chronic expression of low levels of tumor necrosis factor-\u03b1 in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia\/macrophage activation. Neurobiology of Disease 37:630\u2013640","journal-title":"Neurobiology of Disease"},{"key":"9724_CR75","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","volume":"81","author":"MM Fan","year":"2007","unstructured":"Fan MM, Raymond LA (2007) N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington\u2019s disease. Progress in Neurobiology 81:272\u2013293","journal-title":"Progress in Neurobiology"},{"key":"9724_CR76","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/S0002-9440(10)63438-4","volume":"165","author":"CC Ferrari","year":"2004","unstructured":"Ferrari CC, Depino AM, Prada F, Muraro N, Campbell S, Podhajcer O, Perry VH, Anthony DC, Pitossi FJ (2004) Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. The American Journal of Pathology 165:1827\u20131837","journal-title":"The American Journal of Pathology"},{"key":"9724_CR77","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nbt.1515","volume":"27","author":"KD Foust","year":"2009","unstructured":"Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK (2009) Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nature Biotechnology 27:59\u201365","journal-title":"Nature Biotechnology"},{"key":"9724_CR78","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00415-008-1004-6","volume":"255","author":"RJ Franklin","year":"2008","unstructured":"Franklin RJ, Kotter MR (2008) The biology of CNS remyelination. Journal of Neurology 255:19\u201325","journal-title":"Journal of Neurology"},{"key":"9724_CR79","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1586\/ern.09.111","volume":"9","author":"S Fuller","year":"2009","unstructured":"Fuller S, M\u00fcnch G, Steele M (2009) Activated astrocytes: a therapeutic target in Alzheimer\u2019s disease? Expert Review of Neurotherapeutics 9:1585\u20131594","journal-title":"Expert Review of Neurotherapeutics"},{"key":"9724_CR80","doi-asserted-by":"publisher","first-page":"16129","DOI":"10.1523\/JNEUROSCI.2323-12.2012","volume":"32","author":"JL Furman","year":"2012","unstructured":"Furman JL, Sama DM, Gant JC, Beckett TL, Murphy MP, Bachstetter AD, Van Eldik LJ, Norris CM (2012) Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer\u2019s disease. The Journal of Neuroscience 32:16129\u201316140","journal-title":"The Journal of Neuroscience"},{"key":"9724_CR81","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","volume":"31","author":"T Gaj","year":"2013","unstructured":"Gaj T, Gersbach CA, Barbas CF (2013) ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering. Trends in Biotechnology 31:397\u2013405","journal-title":"Trends in Biotechnology"},{"key":"9724_CR82","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/glia.440120405","volume":"12","author":"M Galou","year":"1994","unstructured":"Galou M, Pournin S, Ensergueix D, Ridet JL, Tch\u00e9ling\u00e9rian JL, Lossouran L, Privat A, Babinet C, Dupouey P (1994) Normal and pathological expression of GFAP promoter elements in transgenic mice. Glia 12:281\u2013293","journal-title":"Glia"},{"key":"9724_CR83","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11481-006-9015-5","volume":"1","author":"GA Garden","year":"2006","unstructured":"Garden GA, M\u00f6ller T (2006) Microglia biology in health and disease. Journal of Neuroimmune Pharmacology 1:127\u2013137","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"9724_CR84","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/jnr.10835","volume":"74","author":"J Gardner","year":"2003","unstructured":"Gardner J, Ghorpade A (2003) Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. Journal of Neuroscience Research 74:801\u2013806","journal-title":"Journal of Neuroscience Research"},{"key":"9724_CR85","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3109\/1061186X.2011.589435","volume":"19","author":"W Geldenhuys","year":"2011","unstructured":"Geldenhuys W, Mbimba T, Bui T, Harrison K, Sutariya V (2011) Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers. Journal of Drug Targeting 19:837\u2013845","journal-title":"Journal of Drug Targeting"},{"key":"9724_CR86","doi-asserted-by":"publisher","first-page":"145101","DOI":"10.1088\/0957-4484\/22\/14\/145101","volume":"22","author":"M Geppert","year":"2011","unstructured":"Geppert M, Hohnholt MC, Thiel K, N\u00fcrnberger S, Grunwald I, Rezwan K, Dringen R (2011) Uptake of dimercaptosuccinate-coated magnetic iron oxide nanoparticles by cultured brain astrocytes. Nanotechnology 22:145101","journal-title":"Nanotechnology"},{"key":"9724_CR87","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1006\/mthe.2000.0140","volume":"2","author":"CA Gerdes","year":"2000","unstructured":"Gerdes CA, Castro MG, L\u00f6wenstein PR (2000) Strong promoters are the key to highly efficient, noninflammatory and noncytotoxic adenoviral-mediated transgene delivery into the brain in vivo. Molecular Therapy 2:330","journal-title":"Molecular Therapy"},{"key":"9724_CR88","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1742-4690-3-28","volume":"3","author":"M Ghafouri","year":"2006","unstructured":"Ghafouri M, Amini S, Khalili K, Sawaya BE (2006) HIV-1 associated dementia: symptoms and causes. Retrovirology 3:28","journal-title":"Retrovirology"},{"key":"9724_CR89","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1089\/hgtb.2013.076","volume":"24","author":"S Gholizadeh","year":"2013","unstructured":"Gholizadeh S, Tharmalingam S, MacAldaz ME, Hampson DR (2013) Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice. Human Gene Therapy Methods 24:205\u2013213","journal-title":"Human Gene Therapy Methods"},{"key":"9724_CR90","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/jgm.2698","volume":"15","author":"SL Ginn","year":"2013","unstructured":"Ginn SL, Alexander IE, Edelstein ML, Abedi MR, Wixon J (2013) Gene therapy clinical trials worldwide to 2012\u2013an update. The Journal of Gene Medicine 15:65\u201377","journal-title":"The Journal of Gene Medicine"},{"key":"9724_CR91","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/gt.2010.71","volume":"17","author":"A Giralt","year":"2010","unstructured":"Giralt A, Friedman HC, Caneda-Ferron B, Urban N, Moreno E, Rubio N, Blanco J, Peterson A, Canals JM, Alberch J (2010) BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington\u2019s disease. Gene Therapy 17:1294\u20131308","journal-title":"Gene Therapy"},{"key":"9724_CR92","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.tins.2011.12.006","volume":"35","author":"S Gorantla","year":"2012","unstructured":"Gorantla S, Poluektova L, Gendelman HE (2012) Rodent models for HIV-associated neurocognitive disorders. Trends in Neurosciences 35:197\u2013208","journal-title":"Trends in Neurosciences"},{"key":"9724_CR93","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/sj.gt.3300635","volume":"5","author":"D Goula","year":"1998","unstructured":"Goula D, Remy J, Erbacher P, Wasowicz M, Levi G, Abdallah B, Demeneix B (1998) Size, diffusibility and transfection performance of linear PEI\/DNA complexes in the mouse central nervous system. Gene Therapy 5:712\u2013717","journal-title":"Gene Therapy"},{"key":"9724_CR94","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/mt.2011.72","volume":"19","author":"SJ Gray","year":"2011","unstructured":"Gray SJ, Matagne V, Bachaboina L, Yadav S, Ojeda SR, Samulski RJ (2011) Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates. Molecular Therapy 19:1058\u20131069","journal-title":"Molecular Therapy"},{"key":"9724_CR95","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ceca.2009.12.002","volume":"47","author":"J Grosskreutz","year":"2010","unstructured":"Grosskreutz J, Van Den Bosch L, Keller BU (2010) Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium 47:165\u2013174","journal-title":"Cell Calcium"},{"key":"9724_CR96","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1021\/nn501197v","volume":"8","author":"H Guerrero-C\u00e1zares","year":"2014","unstructured":"Guerrero-C\u00e1zares H, Tzeng SY, Young NP, Abutaleb AO, Qui\u00f1ones-Hinojosa A, Green JJ (2014) Biodegradable polymeric nanoparticles show high efficacy and specificity at DNA delivery to human glioblastoma in vitro and in vivo. ACS Nano 8:5141\u20135153","journal-title":"ACS Nano"},{"key":"9724_CR97","doi-asserted-by":"publisher","first-page":"e0147389","DOI":"10.1371\/journal.pone.0147389","volume":"11","author":"S-J Gwak","year":"2016","unstructured":"Gwak S-J, Yun Y, Kim KN, Ha Y (2016) Therapeutic use of 3\u03b2-[N-(N\u2032, N\u2032-Dimethylaminoethane) Carbamoyl] cholesterol-modified PLGA Nanospheres as Gene delivery vehicles for spinal cord injury. PloS One 11:e0147389","journal-title":"PloS One"},{"key":"9724_CR98","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.molmed.2006.12.005","volume":"13","author":"MM Halassa","year":"2007","unstructured":"Halassa MM, Fellin T, Haydon PG (2007) The tripartite synapse: roles for gliotransmission in health and disease. Trends in Molecular Medicine 13:54\u201363","journal-title":"Trends in Molecular Medicine"},{"key":"9724_CR99","unstructured":"Health USNIo (2016) Neurodegeneration clinical trials. In: NIH"},{"key":"9724_CR100","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1002\/jnr.21432","volume":"85","author":"W Hendriks","year":"2007","unstructured":"Hendriks W, Eggers R, Verhaagen J, Boer G (2007) Gene transfer to the spinal cord neural scar with lentiviral vectors: predominant transgene expression in astrocytes but not in meningeal cells. Journal of Neuroscience Research 85:3041\u20133052","journal-title":"Journal of Neuroscience Research"},{"key":"9724_CR101","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1006\/nbdi.2001.0448","volume":"8","author":"DM Hermann","year":"2001","unstructured":"Hermann DM, Kilic E, K\u00fcgler S, Isenmann S, B\u00e4hr M (2001a) Adenovirus-mediated glial cell line-derived neurotrophic factor (GDNF) expression protects against subsequent cortical cold injury in rats. Neurobiology of Disease 8:964\u2013973","journal-title":"Neurobiology of Disease"},{"key":"9724_CR102","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1006\/nbdi.2001.0399","volume":"8","author":"DM Hermann","year":"2001","unstructured":"Hermann DM, Kilic E, K\u00fcgler S, Isenmann S, B\u00e4hr M (2001b) Adenovirus-mediated GDNF and CNTF pretreatment protects against striatal injury following transient middle cerebral artery occlusion in mice. Neurobiology of Disease 8:655\u2013666","journal-title":"Neurobiology of Disease"},{"key":"9724_CR103","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0301-0082(98)00007-0","volume":"55","author":"WT Hermens","year":"1998","unstructured":"Hermens WT, Verhaagen J (1998) Viral vectors, tools for gene transfer in the nervous system. Progress in Neurobiology 55:399\u2013432","journal-title":"Progress in Neurobiology"},{"key":"9724_CR104","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? The Lancet Neurology 8:382\u2013397","journal-title":"The Lancet Neurology"},{"key":"9724_CR105","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/gt.2011.7","volume":"18","author":"J Homs","year":"2011","unstructured":"Homs J, Ariza L, Pages G, Udina E, Navarro X, Chill\u00f3n M, Bosch A (2011) Schwann cell targeting via intrasciatic injection of AAV8 as gene therapy strategy for peripheral nerve regeneration. Gene Therapy 18:622\u2013630","journal-title":"Gene Therapy"},{"key":"9724_CR106","doi-asserted-by":"publisher","first-page":"11461","DOI":"10.1073\/pnas.1405186111","volume":"111","author":"W Hu","year":"2014","unstructured":"Hu W, Kaminski R, Yang F, Zhang Y, Cosentino L, Li F, Luo B, Alvarez-Carbonell D, Garcia-Mesa Y, Karn J (2014) RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection. Proceedings of the National Academy of Sciences 111:11461\u201311466","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"9724_CR107","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.4049\/jimmunol.181.10.7194","volume":"181","author":"X Hu","year":"2008","unstructured":"Hu X, Zhang D, Pang H, Caudle WM, Li Y, Gao H, Liu Y, Qian L, Wilson B, Di Monte DA (2008) Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson\u2019s disease. Journal of Immunology 181:7194\u20137204","journal-title":"Journal of Immunology"},{"key":"9724_CR108","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1089\/104303401750476230","volume":"12","author":"D-Y Hwang","year":"2001","unstructured":"Hwang D-Y, Carlezon WA Jr, Isacson O, Kim K-S (2001) A high-efficiency synthetic promoter that drives transgene expression selectively in noradrenergic neurons. Human Gene Therapy 12:1731\u20131740","journal-title":"Human Gene Therapy"},{"key":"9724_CR109","unstructured":"Institut USN, Health eo (2016) Ibudilast clinical trials. In: p Search results on for Ibudilast clinical trials"},{"key":"9724_CR110","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s13346-011-0046-y","volume":"1","author":"H Jaffer","year":"2011","unstructured":"Jaffer H, Morris VB, Stewart D, Labhasetwar V (2011) Advances in stroke therapy. Drug Delivery and Translational Research 1:409\u2013419","journal-title":"Drug Delivery and Translational Research"},{"key":"9724_CR111","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/jnr.10719","volume":"73","author":"J Jakobsson","year":"2003","unstructured":"Jakobsson J, Ericson C, Jansson M, Bj\u00f6rk E, Lundberg C (2003) Targeted transgene expression in rat brain using lentiviral vectors. Journal of Neuroscience Research 73:876\u2013885","journal-title":"Journal of Neuroscience Research"},{"key":"9724_CR112","doi-asserted-by":"publisher","first-page":"209ra152","DOI":"10.1126\/scitranslmed.3006839","volume":"5","author":"SA Jensen","year":"2013","unstructured":"Jensen SA, Day ES, Ko CH, Hurley LA, Luciano JP, Kouri FM, Merkel TJ, Luthi AJ, Patel PC, Cutler JI (2013) Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Science Translational Medicine 5:209ra152","journal-title":"Science Translational Medicine"},{"key":"9724_CR113","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2165\/11538400-000000000-00000","volume":"24","author":"JL Jim\u00e9nez","year":"2010","unstructured":"Jim\u00e9nez JL, Clemente MI, Weber ND, Sanchez J, Ortega P, de la Mata FJ, G\u00f3mez R, Garc\u00eda D, L\u00f3pez-Fern\u00e1ndez LA, Mu\u00f1oz-Fern\u00e1ndez M\u00c1 (2010) Carbosilane dendrimers to transfect human astrocytes with small interfering RNA targeting human immunodeficiency virus. BioDrugs 24:331\u2013343","journal-title":"BioDrugs"},{"key":"9724_CR114","doi-asserted-by":"publisher","first-page":"8339","DOI":"10.1039\/c3cs60145e","volume":"42","author":"F Joris","year":"2013","unstructured":"Joris F, Manshian BB, Peynshaert K, De Smedt SC, Braeckmans K, Soenen SJ (2013) Assessing nanoparticle toxicity in cell-based assays: influence of cell culture parameters and optimized models for bridging the in vitro\u2013in vivo gap. Chemical Society Reviews 42:8339\u20138359","journal-title":"Chemical Society Reviews"},{"key":"9724_CR115","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/nm.2224","volume":"16","author":"M Jucker","year":"2010","unstructured":"Jucker M (2010) The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nature Medicine 16:1210\u20131214","journal-title":"Nature Medicine"},{"key":"9724_CR116","doi-asserted-by":"publisher","first-page":"28213","DOI":"10.1038\/srep28213","volume":"6","author":"R Kaminski","year":"2016","unstructured":"Kaminski R, Chen Y, Fischer T, Tedaldi E, Napoli A, Zhang Y, Karn J, Hu W, Khalili K (2016) Elimination of HIV-1 genomes from human T-lymphoid cells by CRISPR\/Cas9 gene editing. Scientific Reports 6:28213","journal-title":"Scientific Reports"},{"key":"9724_CR117","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","volume":"369","author":"MG Kaplitt","year":"2007","unstructured":"Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, Bland RJ, Young D, Strybing K, Eidelberg D (2007) Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson\u2019s disease: an open label, phase I trial. Lancet 369:2097\u20132105","journal-title":"Lancet"},{"key":"9724_CR118","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1089\/hum.2013.2517","volume":"24","author":"MG Katz","year":"2013","unstructured":"Katz MG, Fargnoli AS, Williams RD, Bridges CR (2013) Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applications. Human Gene Therapy 24:914\u2013927","journal-title":"Human Gene Therapy"},{"key":"9724_CR119","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0002-9440(10)64304-0","volume":"162","author":"BO Kim","year":"2003","unstructured":"Kim BO, Liu Y, Ruan Y, ZC X, Schantz L, He JJ (2003) Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. The American Journal of Pathology 162:1693\u20131707","journal-title":"The American Journal of Pathology"},{"key":"9724_CR120","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jconrel.2009.11.011","volume":"142","author":"I-D Kim","year":"2010","unstructured":"Kim I-D, Lim C-M, Kim J-B, Nam HY, Nam K, Kim S-W, Park J-S, Lee J-K (2010) Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain. Journal of Controlled Release 142:422\u2013430","journal-title":"Journal of Controlled Release"},{"key":"9724_CR121","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/mt.2011.291","volume":"20","author":"I-D Kim","year":"2012","unstructured":"Kim I-D, Shin J-H, Kim S-W, Choi S, Ahn J, Han P-L, Park J-S, Lee J-K (2012) Intranasal delivery of HMGB1 siRNA confers target gene knockdown and robust neuroprotection in the postischemic brain. Molecular Therapy 20:829\u2013839","journal-title":"Molecular Therapy"},{"key":"9724_CR122","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jconrel.2006.05.011","volume":"114","author":"J-B Kim","year":"2006","unstructured":"Kim J-B, Choi JS, Nam K, Lee M, Park J-S, Lee J-K (2006) Enhanced transfection of primary cortical cultures using arginine-grafted PAMAM dendrimer, PAMAM-Arg. Journal of Controlled Release 114:110\u2013117","journal-title":"Journal of Controlled Release"},{"key":"9724_CR123","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/mt.2009.44","volume":"17","author":"T Kiyota","year":"2009","unstructured":"Kiyota T, Yamamoto M, Schroder B, Jacobsen MT, Swan RJ, Lambert MP, Klein WL, Gendelman HE, Ransohoff RM, Ikezu T (2009) AAV1\/2-mediated CNS gene delivery of dominant-negative CCL2 mutant suppresses gliosis, \u03b2-amyloidosis, and learning impairment of APP\/PS1 mice. Molecular Therapy 17:803\u2013809","journal-title":"Molecular Therapy"},{"key":"9724_CR124","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jneumeth.2007.06.011","volume":"165","author":"I Klejbor","year":"2007","unstructured":"Klejbor I, Stachowiak E, Bharali D, Roy I, Spodnik I, Morys J, Bergey E, Prasad P, Stachowiak M (2007) ORMOSIL nanoparticles as a non-viral gene delivery vector for modeling polyglutamine induced brain pathology. Journal of Neuroscience Methods 165:230\u2013243","journal-title":"Journal of Neuroscience Methods"},{"key":"9724_CR125","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1038\/mt.2009.184","volume":"17","author":"JT Koerber","year":"2009","unstructured":"Koerber JT, Klimczak R, Jang J-H, Dalkara D, Flannery JG, Schaffer DV (2009) Molecular evolution of adeno-associated virus for enhanced glial gene delivery. Molecular Therapy 17:2088\u20132095","journal-title":"Molecular Therapy"},{"key":"9724_CR126","doi-asserted-by":"crossref","unstructured":"Kordower J, Bjorklund A (2013) Trophic factor gene therapy for Parkinson's disease. Movement Disorders 28(1): 96-109","DOI":"10.1002\/mds.25344"},{"key":"9724_CR127","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","volume":"71","author":"J Kreuter","year":"2014","unstructured":"Kreuter J (2014) Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Advanced Drug Delivery Reviews 71:2\u201314","journal-title":"Advanced Drug Delivery Reviews"},{"key":"9724_CR128","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0042-6822(03)00162-4","volume":"311","author":"S K\u00fcgler","year":"2003","unstructured":"K\u00fcgler S, Lingor P, Sch\u00f6ll U, Zolotukhin S, B\u00e4hr M (2003) Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control units. Virology 311:89\u201395","journal-title":"Virology"},{"key":"9724_CR129","first-page":"1217","volume":"2011","author":"B Kuhn","year":"2011","unstructured":"Kuhn B, Hoogland TM, Wang SS-H (2011) Injection of recombinant adenovirus for delivery of genetically encoded calcium indicators into astrocytes of the cerebellar cortex. Cold Spring Harbor Protocols 2011:1217\u20131223","journal-title":"Cold Spring Harbor Protocols"},{"key":"9724_CR130","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.biomaterials.2009.11.086","volume":"31","author":"EJ Kwon","year":"2010","unstructured":"Kwon EJ, Lasiene J, Jacobson BE, Park I-K, Horner PJ, Pun SH (2010) Targeted nonviral delivery vehicles to neural progenitor cells in the mouse subventricular zone. Biomaterials 31:2417\u20132424","journal-title":"Biomaterials"},{"key":"9724_CR131","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.pneurobio.2013.11.006","volume":"115","author":"TW Lai","year":"2014","unstructured":"Lai TW, Zhang S, Wang YT (2014) Excitotoxicity and stroke: identifying novel targets for neuroprotection. Progress in Neurobiology 115:157\u2013188","journal-title":"Progress in Neurobiology"},{"key":"9724_CR132","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/jnr.10137","volume":"67","author":"Z Lai","year":"2002","unstructured":"Lai Z, Brady RO (2002) Gene transfer into the central nervous system in vivo using a recombinanat lentivirus vector. Journal of Neuroscience Research 67:363\u2013371","journal-title":"Journal of Neuroscience Research"},{"key":"9724_CR133","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/mt.2009.170","volume":"17","author":"PA Lawlor","year":"2009","unstructured":"Lawlor PA, Bland RJ, Mouravlev A, Young D, During MJ (2009) Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates. Molecular Therapy 17:1692\u20131702","journal-title":"Molecular Therapy"},{"key":"9724_CR134","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/glia.20622","volume":"56","author":"Y Lee","year":"2008","unstructured":"Lee Y, Messing A, Su M, Brenner M (2008) GFAP promoter elements required for region-specific and astrocyte-specific expression. Glia 56:481\u2013493","journal-title":"Glia"},{"key":"9724_CR135","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1474-4422(11)70039-4","volume":"10","author":"PA LeWitt","year":"2011","unstructured":"LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Thomas K, Sarkar A, Siddiqui MS (2011) AAV2-GAD gene therapy for advanced Parkinson\u2019s disease: a double-blind, sham-surgery controlled, randomised trial. The Lancet Neurology 10:309\u2013319","journal-title":"The Lancet Neurology"},{"key":"9724_CR136","doi-asserted-by":"crossref","first-page":"7228","DOI":"10.1523\/JNEUROSCI.17-19-07228.1997","volume":"17","author":"F Lisovoski","year":"1997","unstructured":"Lisovoski F, Akli S, Peltekian E, Vigne E, Haase G, Perricaudet M, Dreyfus PA, Kahn A, Peschanski M (1997) Phenotypic alteration of astrocytes induced by ciliary neurotrophic factor in the intact adult brain, as revealed by adenovirus-mediated gene transfer. The Journal of Neuroscience 17:7228\u20137236","journal-title":"The Journal of Neuroscience"},{"key":"9724_CR137","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1038\/sj.gt.3302554","volume":"12","author":"G Liu","year":"2005","unstructured":"Liu G, Martins I, Chiorini J, Davidson B (2005) Adeno-associated virus type 4 (AAV4) targets ependyma and astrocytes in the subventricular zone and RMS. Gene Therapy 12:1503\u20131508","journal-title":"Gene Therapy"},{"key":"9724_CR138","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0006-8993(97)00587-8","volume":"768","author":"Y Liu","year":"1997","unstructured":"Liu Y, Himes BT, Moul J, Huang W, Chow SY, Tessler A, Fischer I (1997) Application of recombinant adenovirus for in vivo gene delivery to spinal cord. Brain Research 768:19\u201329","journal-title":"Brain Research"},{"key":"9724_CR139","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.brainres.2012.10.039","volume":"1490","author":"Y Liu","year":"2013","unstructured":"Liu Y, Liu Z, Wang Y, Liang Y-R, Wen X, Hu J, Yang X, Liu J, Xiao S, Cheng D (2013) Investigation of the performance of PEG\u2013PEI\/ROCK-II-siRNA complexes for Alzheimer\u2019s disease in vitro. Brain Research 1490:43\u201351","journal-title":"Brain Research"},{"key":"9724_CR140","doi-asserted-by":"publisher","first-page":"9336","DOI":"10.1523\/JNEUROSCI.3975-14.2015","volume":"35","author":"Y Liu","year":"2015","unstructured":"Liu Y, Miao Q, Yuan J, Han S, Zhang P, Li S, Rao Z, Zhao W, Ye Q, Geng J (2015) Ascl1 converts dorsal midbrain astrocytes into functional neurons in vivo. The Journal of Neuroscience 35:9336\u20139355","journal-title":"The Journal of Neuroscience"},{"key":"9724_CR141","doi-asserted-by":"publisher","first-page":"628070","DOI":"10.1155\/2012\/628070","volume":"2012","author":"K Lobello","year":"2012","unstructured":"Lobello K, Ryan JM, Liu E, Rippon G, Black R (2012) Targeting Beta amyloid: a clinical review of immunotherapeutic approaches in Alzheimer\u2019s disease. International Journal of Alzheimer's Disease 2012:628070","journal-title":"International Journal of Alzheimer's Disease"},{"key":"9724_CR142","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1021\/mp5006883","volume":"12","author":"S Lu","year":"2015","unstructured":"Lu S, Morris VB, Labhasetwar V (2015) Codelivery of DNA and siRNA via arginine-rich PEI-based polyplexes. Molecular Pharmaceutics 12:621\u2013629","journal-title":"Molecular Pharmaceutics"},{"key":"9724_CR143","doi-asserted-by":"publisher","first-page":"e23915","DOI":"10.1371\/journal.pone.0023915","volume":"6","author":"S-M Lu","year":"2011","unstructured":"Lu S-M, Tremblay M-\u00c8, King IL, Qi J, Reynolds HM, Marker DF, Varrone JJ, Majewska AK, Dewhurst S, Gelbard HA (2011) HIV-1 tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells. PloS One 6:e23915","journal-title":"PloS One"},{"key":"9724_CR144","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1089\/hum.2014.003","volume":"25","author":"NB Lu-Nguyen","year":"2014","unstructured":"Lu-Nguyen NB, Broadstock M, Schliesser MG, Bartholomae CC, von Kalle C, Schmidt M, Y\u00e1\u00f1ez-Mu\u00f1oz RJ (2014) Transgenic expression of human glial cell line-derived neurotrophic factor from integration-deficient lentiviral vectors is neuroprotective in a rodent model of Parkinson\u2019s disease. Human Gene Therapy 25:631\u2013641","journal-title":"Human Gene Therapy"},{"key":"9724_CR145","doi-asserted-by":"publisher","first-page":"375101","DOI":"10.1088\/0957-4484\/22\/37\/375101","volume":"22","author":"EM Luther","year":"2011","unstructured":"Luther EM, Koehler Y, Diendorf J, Epple M, Dringen R (2011) Accumulation of silver nanoparticles by cultured primary brain astrocytes. Nanotechnology 22:375101","journal-title":"Nanotechnology"},{"key":"9724_CR146","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.2217\/nnm.13.183","volume":"8","author":"M Malhotra","year":"2013","unstructured":"Malhotra M, Tomaro-Duchesneau C, Saha S, Kahouli I, Prakash S (2013) Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA. International Journal of Nanomedicine 8:2041\u20132052","journal-title":"International Journal of Nanomedicine"},{"key":"9724_CR147","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.mito.2005.01.002","volume":"5","author":"G Manfredi","year":"2005","unstructured":"Manfredi G, Xu Z (2005) Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion 5:77\u201387","journal-title":"Mitochondrion"},{"key":"9724_CR148","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1021\/nn504905q","volume":"9","author":"A Mangraviti","year":"2015","unstructured":"Mangraviti A, Tzeng SY, Kozielski KL, Wang Y, Jin Y, Gullotti D, Pedone M, Buaron N, Liu A, Wilson DR (2015) Polymeric nanoparticles for nonviral gene therapy extend brain tumor survival in vivo. ACS Nano 9:1236\u20131249","journal-title":"ACS Nano"},{"key":"9724_CR149","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/adhm.201400800","volume":"4","author":"P Mastorakos","year":"2015","unstructured":"Mastorakos P, Zhang C, Berry S, Oh Y, Lee S, Eberhart CG, Woodworth GF, Suk JS, Hanes J (2015) Highly PEGylated DNA nanoparticles provide uniform and widespread gene transfer in the brain. Advanced Healthcare Materials 4:1023\u20131033","journal-title":"Advanced Healthcare Materials"},{"key":"9724_CR150","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/jnr.20626","volume":"82","author":"SR McIver","year":"2005","unstructured":"McIver SR, Lee CS, Lee JM, Green SH, Sands MS, Snider BJ, Goldberg MP (2005) Lentiviral transduction of murine oligodendrocytes in vivo. Journal of Neuroscience Research 82:397\u2013403","journal-title":"Journal of Neuroscience Research"},{"key":"9724_CR151","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1750-3639.1996.tb00858.x","volume":"6","author":"FA McMorris","year":"1996","unstructured":"McMorris FA, McKinnon RD (1996) Regulation of oligodendrocyte development and CNS myelination by growth factors: prospects for therapy of demyelinating disease. Brain Pathology 6:313\u2013329","journal-title":"Brain Pathology"},{"key":"9724_CR152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1471-4159.2008.05570.x","volume":"107","author":"DM McTigue","year":"2008","unstructured":"McTigue DM, Tripathi RB (2008) The life, death, and replacement of oligodendrocytes in the adult CNS. Journal of Neurochemistry 107:1\u201319","journal-title":"Journal of Neurochemistry"},{"key":"9724_CR153","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.neulet.2015.03.022","volume":"593","author":"X Meng","year":"2015","unstructured":"Meng X, Yang F, Ouyang T, Liu B, Wu C, Jiang W (2015) Specific gene expression in mouse cortical astrocytes is mediated by a 1740\u00a0bp-GFAP promoter-driven combined adeno-associated virus 2\/5\/7\/8\/9. Neuroscience Letters 593:45\u201350","journal-title":"Neuroscience Letters"},{"key":"9724_CR154","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/gt.2015.54","volume":"22","author":"N Merienne","year":"2015","unstructured":"Merienne N, Delzor A, Viret A, Dufour N, Rey M, Hantraye P, D\u00e9glon N (2015) Gene transfer engineering for astrocyte-specific silencing in the CNS. Gene Therapy 22:830\u2013839","journal-title":"Gene Therapy"},{"key":"9724_CR155","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1046\/j.1365-2990.1999.00200.x","volume":"25","author":"J Merrill","year":"1999","unstructured":"Merrill J, Scolding N (1999) Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease. Neuropathology and Applied Neurobiology 25:435\u2013458","journal-title":"Neuropathology and Applied Neurobiology"},{"key":"9724_CR156","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2174\/156652308786071014","volume":"8","author":"P Midoux","year":"2008","unstructured":"Midoux P, Breuzard G, Gomez JP, Pichon C (2008) Polymer-based gene delivery: a current review on the uptake and intracellular trafficking of polyplexes. Current Gene Therapy 8:335\u2013352","journal-title":"Current Gene Therapy"},{"key":"9724_CR157","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1017\/S1740925X07000488","volume":"2","author":"ED Milligan","year":"2006","unstructured":"Milligan ED, Soderquist RG, Malone SM, Mahoney JH, Hughes TS, Langer SJ, Sloane EM, Maier SF, Leinwand LA, Watkins LR (2006) Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain. Neuron Glia Biology 2:293\u2013308","journal-title":"Neuron Glia Biology"},{"key":"9724_CR158","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.brainres.2011.03.014","volume":"1389","author":"N Miyake","year":"2011","unstructured":"Miyake N, Miyake K, Yamamoto M, Hirai Y, Shimada T (2011) Global gene transfer into the CNS across the BBB after neonatal systemic delivery of single-stranded AAV vectors. Brain Research 1389:19\u201326","journal-title":"Brain Research"},{"key":"9724_CR159","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.biomaterials.2015.04.052","volume":"60","author":"VB Morris","year":"2015","unstructured":"Morris VB, Labhasetwar V (2015) Arginine-rich polyplexes for gene delivery to neuronal cells. Biomaterials 60:151\u2013160","journal-title":"Biomaterials"},{"key":"9724_CR160","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1089\/neu.2006.0004","volume":"24","author":"H Nakajima","year":"2007","unstructured":"Nakajima H, Uchida K, Kobayashi S, Inukai T, Horiuchi Y, Yayama T, Sato R, Baba H (2007) Rescue of rat anterior horn neurons after spinal cord injury by retrograde transfection of adenovirus vector carrying brain-derived neurotrophic factor gene. Journal of Neurotrauma 24:703\u2013712","journal-title":"Journal of Neurotrauma"},{"key":"9724_CR161","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.272.5259.263","volume":"272","author":"L Naldini","year":"1996","unstructured":"Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage F, Verma I, Trono D (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263","journal-title":"Science"},{"key":"9724_CR162","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1038\/sj.gt.3301008","volume":"6","author":"V Navarro","year":"1999","unstructured":"Navarro V, Millecamps S, Geoffroy M, Robert J, Valin A, Mallet J, Le Gal La Salle G (1999) Efficient gene transfer and long-term expression in neurons using a recombinant adenovirus with a neuron-specific promoter. Gene Therapy 6:1884\u20131892","journal-title":"Gene Therapy"},{"key":"9724_CR163","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1021\/cn4000023","volume":"4","author":"B Newland","year":"2013","unstructured":"Newland B, Abu-Rub M, Naughton M, Zheng Y, Pinoncely A, Collin E, Dowd E, Wang W, Pandit A (2013) GDNF gene delivery via a 2-(dimethylamino) ethyl methacrylate based cyclized knot polymer for neuronal cell applications. ACS Chemical Neuroscience 4:540\u2013546","journal-title":"ACS Chemical Neuroscience"},{"key":"9724_CR164","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1096\/fj.02-1183fje","volume":"17","author":"GP Nicchia","year":"2003","unstructured":"Nicchia GP, Frigeri A, Liuzzi GM, Svelto M (2003) Inhibition of aquaporin-4 expression in astrocytes by RNAi determines alteration in cell morphology, growth, and water transport and induces changes in ischemia-related genes. The FASEB Journal 17:1508\u20131510","journal-title":"The FASEB Journal"},{"key":"9724_CR165","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12035-013-8483-x","volume":"49","author":"R Niranjan","year":"2014","unstructured":"Niranjan R (2014) The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson\u2019s disease: focus on astrocytes. Molecular Neurobiology 49:28\u201338","journal-title":"Molecular Neurobiology"},{"key":"9724_CR166","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/1098-1136(20010101)33:1<72::AID-GLIA1007>3.0.CO;2-A","volume":"33","author":"C Nolte","year":"2001","unstructured":"Nolte C, Matyash M, Pivneva T, Schipke CG, Ohlemeyer C, Hanisch UK, Kirchhoff F, Kettenmann H (2001) GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue. Glia 33:72\u201386","journal-title":"Glia"},{"key":"9724_CR167","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0304-3940(03)00095-8","volume":"340","author":"T Nomoto","year":"2003","unstructured":"Nomoto T, Okada T, Shimazaki K, Mizukami H, Matsushita T, Hanazono Y, Kume A, Katsura K-i, Katayama Y, Ozawa K (2003) Distinct patterns of gene transfer to gerbil hippocampus with recombinant adeno-associated virus type 2 and 5. Neuroscience Letters 340:153\u2013157","journal-title":"Neuroscience Letters"},{"key":"9724_CR168","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S0140-6736(13)61939-X","volume":"383","author":"S Palfi","year":"2014","unstructured":"Palfi S, Gurruchaga JM, Ralph GS, Lepetit H, Lavisse S, Buttery PC, Watts C, Miskin J, Kelleher M, Deeley S (2014) Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson\u2019s disease: a dose escalation, open-label, phase 1\/2 trial. Lancet 383:1138\u20131146","journal-title":"Lancet"},{"key":"9724_CR169","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0896-6273(02)01054-1","volume":"36","author":"WM Pardridge","year":"2002","unstructured":"Pardridge WM (2002) Drug and gene delivery to the brain: the vascular route. Neuron 36:555\u2013558","journal-title":"Neuron"},{"key":"9724_CR170","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/jgm.1062","volume":"9","author":"IK Park","year":"2007","unstructured":"Park IK, Lasiene J, Chou SH, Horner PJ, Pun SH (2007) Neuron-specific delivery of nucleic acids mediated by Tet1-modified poly (ethylenimine). The Journal of Gene Medicine 9:691\u2013702","journal-title":"The Journal of Gene Medicine"},{"key":"9724_CR171","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/sj.gt.3300358","volume":"4","author":"A Peel","year":"1997","unstructured":"Peel A, Zolotukhin S, Schrimsher G, Muzyczka N, Reier P (1997) Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell-type specific promoters. Gene Therapy 4:16\u201324","journal-title":"Gene Therapy"},{"key":"9724_CR172","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0165-0270(00)00183-7","volume":"98","author":"AL Peel","year":"2000","unstructured":"Peel AL, Klein RL (2000) Adeno-associated virus vectors: activity and applications in the CNS. Journal of Neuroscience Methods 98:95\u2013104","journal-title":"Journal of Neuroscience Methods"},{"key":"9724_CR173","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1189\/jlb.68.3.413","volume":"68","author":"Y Persidsky","year":"2000","unstructured":"Persidsky Y, Zheng J, Miller D, Gendelman HE (2000) Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. Journal of Leukocyte Biology 68:413\u2013422","journal-title":"Journal of Leukocyte Biology"},{"key":"9724_CR174","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/gt.2014.74","volume":"21","author":"H Petrosyan","year":"2014","unstructured":"Petrosyan H, Alessi V, Singh V, Hunanyan A, Levine J, Arvanian V (2014) Transduction efficiency of neurons and glial cells by AAV-1,-5,-9,-rh10 and-hu11 serotypes in rat spinal cord following contusion injury. Gene Therapy 21:991\u20131000","journal-title":"Gene Therapy"},{"key":"9724_CR175","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jneumeth.2011.12.024","volume":"205","author":"M Peviani","year":"2012","unstructured":"Peviani M, Kurosaki M, Terao M, Lidonnici D, Gensano F, Battaglia E, Tortarolo M, Piva R, Bendotti C (2012) Lentiviral vectors carrying enhancer elements of Hb9 promoter drive selective transgene expression in mouse spinal cord motor neurons. Journal of Neuroscience Methods 205:139\u2013147","journal-title":"Journal of Neuroscience Methods"},{"key":"9724_CR176","doi-asserted-by":"publisher","first-page":"e62241","DOI":"10.1371\/journal.pone.0062241","volume":"8","author":"S Pilakka-Kanthikeel","year":"2013","unstructured":"Pilakka-Kanthikeel S, Atluri VSR, Sagar V, Saxena SK, Nair M (2013) Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study. PloS One 8:e62241","journal-title":"PloS One"},{"key":"9724_CR177","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.pneurobio.2010.06.009","volume":"92","author":"E Polazzi","year":"2010","unstructured":"Polazzi E, Monti B (2010) Microglia and neuroprotection: from in vitro studies to therapeutic applications. Progress in Neurobiology 92:293\u2013315","journal-title":"Progress in Neurobiology"},{"key":"9724_CR178","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-pathol-011811-132443","volume":"7","author":"BFG Popescu","year":"2012","unstructured":"Popescu BFG, Lucchinetti CF (2012) Pathology of demyelinating diseases. Annual Review of Pathology: Mechanisms of Disease 7:185\u2013217","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"key":"9724_CR179","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.ymthe.2004.12.020","volume":"11","author":"MA Rafi","year":"2005","unstructured":"Rafi MA, Rao HZ, Passini MA, Curtis M, Vanier MT, Zaka M, Luzi P, Wolfe JH, Wenger DA (2005) AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy. Molecular Therapy 11:734\u2013744","journal-title":"Molecular Therapy"},{"key":"9724_CR180","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jalz.2013.09.004","volume":"10","author":"MS Rafii","year":"2014","unstructured":"Rafii MS, Baumann TL, Bakay RA, Ostrove JM, Siffert J, Fleisher AS, Herzog CD, Barba D, Pay M, Salmon DP (2014) A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer\u2019s disease. Alzheimers Dement 10:571\u2013581","journal-title":"Alzheimers Dement"},{"key":"9724_CR181","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/gt.2008.186","volume":"16","author":"A Rahim","year":"2009","unstructured":"Rahim A, Wong A, Howe S, Buckley S, Acosta-Saltos A, Elston K, Ward N, Philpott N, Cooper J, Anderson P (2009) Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors. Gene Therapy 16:509\u2013520","journal-title":"Gene Therapy"},{"key":"9724_CR182","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1096\/fj.11-182311","volume":"25","author":"AA Rahim","year":"2011","unstructured":"Rahim AA, Wong AM, Hoefer K, Buckley SM, Mattar CN, Cheng SH, Chan JK, Cooper JD, Waddington SN (2011) Intravenous administration of AAV2\/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system. The FASEB Journal 25:3505\u20133518","journal-title":"The FASEB Journal"},{"key":"9724_CR183","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1016\/j.biomaterials.2008.08.004","volume":"29","author":"KS Rao","year":"2008","unstructured":"Rao KS, Reddy MK, Horning JL, Labhasetwar V (2008) TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials 29:4429\u20134438","journal-title":"Biomaterials"},{"key":"9724_CR184","first-page":"458624","volume":"2015","author":"S Rao","year":"2015","unstructured":"Rao S, Morales AA, Pearse DD (2015) The comparative utility of Viromer RED and lipofectamine for transient Gene introduction into glial cells. BioMed Research International 2015:458624","journal-title":"BioMed Research International"},{"key":"9724_CR185","doi-asserted-by":"publisher","first-page":"6607","DOI":"10.1523\/JNEUROSCI.0790-07.2007","volume":"27","author":"MR Regan","year":"2007","unstructured":"Regan MR, Huang YH, Kim YS, Dykes-Hoberg MI, Jin L, Watkins AM, Bergles DE, Rothstein JD (2007) Variations in promoter activity reveal a differential expression and physiology of glutamate transporters by glia in the developing and mature CNS. The Journal of Neuroscience 27:6607\u20136619","journal-title":"The Journal of Neuroscience"},{"key":"9724_CR186","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11481-006-9012-8","volume":"1","author":"RB Rock","year":"2006","unstructured":"Rock RB, Peterson PK (2006) Microglia as a pharmacological target in infectious and inflammatory diseases of the brain. Journal of Neuroimmune Pharmacology 1:117\u2013126","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"9724_CR187","first-page":"53","volume":"16","author":"JM Rodgers","year":"2013","unstructured":"Rodgers JM, Robinson AP, Miller SD (2013) Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis. Discovery Medicine 16:53","journal-title":"Discovery Medicine"},{"key":"9724_CR188","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jconrel.2011.08.026","volume":"157","author":"M-L Rogers","year":"2012","unstructured":"Rogers M-L, Rush RA (2012) Non-viral gene therapy for neurological diseases, with an emphasis on targeted gene delivery. Journal of Controlled Release 157:183\u2013189","journal-title":"Journal of Controlled Release"},{"key":"9724_CR189","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1038\/sj.gt.3300774","volume":"5","author":"M Romero","year":"1998","unstructured":"Romero M, Smith G (1998) Adenoviral gene transfer into the normal and injured spinal cord: enhanced transgene stability by combined administration of temperature-sensitive virus and transient immune blockade. Gene Therapy 5:1612\u20131621","journal-title":"Gene Therapy"},{"key":"9724_CR190","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1038\/mtna.2013.65","volume":"2","author":"RL Rungta","year":"2013","unstructured":"Rungta RL, Choi HB, Lin PJ, Ko RW, Ashby D, Nair J, Manoharan M, Cullis PR, MacVicar BA (2013) Lipid nanoparticle delivery of siRNA to silence neuronal gene expression in the brain. Molecular Therapy--Nucleic Acids 2:e136","journal-title":"Molecular Therapy--Nucleic Acids"},{"key":"9724_CR191","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/mt.2013.266","volume":"22","author":"L Samaranch","year":"2014","unstructured":"Samaranch L, San Sebastian W, Kells AP, Salegio EA, Heller G, Bringas JR, Pivirotto P, DeArmond S, Forsayeth J, Bankiewicz KS (2014) AAV9-mediated expression of a non-self protein in nonhuman primate central nervous system triggers widespread neuroinflammation driven by antigen-presenting cell transduction. Molecular Therapy 22:329\u2013337","journal-title":"Molecular Therapy"},{"key":"9724_CR192","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/gt.2013.48","volume":"20","author":"W San Sebastian","year":"2013","unstructured":"San Sebastian W, Samaranch L, Heller G, Kells AP, Bringas J, Pivirotto P, Forsayeth J, Bankiewicz KS (2013) Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain. Gene Therapy 20:1178\u20131183","journal-title":"Gene Therapy"},{"key":"9724_CR193","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.nbd.2008.11.016","volume":"33","author":"JK Sandhu","year":"2009","unstructured":"Sandhu JK, Gardaneh M, Iwasiow R, Lanthier P, Gangaraju S, Ribecco-Lutkiewicz M, Tremblay R, Kiuchi K, Sikorska M (2009) Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity. Neurobiology of Disease 33:405\u2013414","journal-title":"Neurobiology of Disease"},{"key":"9724_CR194","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/bmj.318.7179.311","volume":"318","author":"AH Schapira","year":"1999","unstructured":"Schapira AH (1999) Science, medicine, and the future: Parkinson\u2019s disease. BMJ 318:311\u2013314","journal-title":"BMJ"},{"key":"9724_CR195","first-page":"72","volume":"8","author":"DJ Schuster","year":"2015","unstructured":"Schuster DJ, Dykstra JA, Riedl MS, Kitto KF, Belur LR, McIvor RS, Elde RP, Fairbanks CA, Vulchanova L (2015) Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse. Neuroanatomy and Transgenic Technologies 8:72-85","journal-title":"Neuroanatomy and Transgenic Technologies"},{"key":"9724_CR196","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/sj.gt.3300776","volume":"5","author":"J Segovia","year":"1998","unstructured":"Segovia J, Vergara P, Brenner M (1998) Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental parkinsonism. Gene Therapy 5:1650\u20131655","journal-title":"Gene Therapy"},{"key":"9724_CR197","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jconrel.2014.12.042","volume":"200","author":"MJ Serram\u00eda","year":"2015","unstructured":"Serram\u00eda MJ, \u00c1lvarez S, Fuentes-Paniagua E, Clemente MI, S\u00e1nchez-Nieves J, G\u00f3mez R, de la Mata J, Mu\u00f1oz-Fern\u00e1ndez M\u00c1 (2015) In vivo delivery of siRNA to the brain by carbosilane dendrimer. Journal of Controlled Release 200:60\u201370","journal-title":"Journal of Controlled Release"},{"key":"9724_CR198","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s13346-013-0133-3","volume":"3","author":"L Shah","year":"2013","unstructured":"Shah L, Yadav S, Amiji M (2013) Nanotechnology for CNS delivery of bio-therapeutic agents. Drug Delivery and Translational Research 3:336\u2013351","journal-title":"Drug Delivery and Translational Research"},{"key":"9724_CR199","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/sj.gt.3303048","volume":"15","author":"F Shen","year":"2008","unstructured":"Shen F, Fan Y, Su H, Zhu Y, Chen Y, Liu W, Young WL, Yang G-Y (2008) Adeno-associated viral vector-mediated hypoxia-regulated VEGF gene transfer promotes angiogenesis following focal cerebral ischemia in mice. Gene Therapy 15:30\u201339","journal-title":"Gene Therapy"},{"key":"9724_CR200","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1113\/expphysiol.2004.028159","volume":"90","author":"Z Shevtsova","year":"2005","unstructured":"Shevtsova Z, Malik JM, Michel U, Bahr M, Kugler S (2005) Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo. Experimental Physiology 90:53\u201359","journal-title":"Experimental Physiology"},{"key":"9724_CR201","doi-asserted-by":"publisher","first-page":"12754","DOI":"10.1073\/pnas.221450098","volume":"98","author":"N Shi","year":"2001","unstructured":"Shi N, Zhang Y, Zhu C, Boado RJ, Pardridge WM (2001) Brain-specific expression of an exogenous gene after iv administration. Proceedings of the National Academy of Sciences 98:12754\u201312759","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"9724_CR202","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","volume":"20","author":"A Silvestroni","year":"2009","unstructured":"Silvestroni A, Faull RL, Strand AD, M\u00f6ller T (2009) Distinct neuroinflammatory profile in post-mortem human Huntington\u2019s disease. Neuroreport 20:1098\u20131103","journal-title":"Neuroreport"},{"key":"9724_CR203","doi-asserted-by":"publisher","first-page":"44826","DOI":"10.1074\/jbc.M308643200","volume":"278","author":"ND Sonawane","year":"2003","unstructured":"Sonawane ND, Szoka FC, Verkman A (2003) Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. The Journal of Biological Chemistry 278:44826\u201344831","journal-title":"The Journal of Biological Chemistry"},{"issue":"Suppl 1","key":"9724_CR204","doi-asserted-by":"publisher","first-page":"I32","DOI":"10.1007\/s00415-006-1108-9","volume":"253","author":"M Stangel","year":"2006","unstructured":"Stangel M, Gold R, Gass A, Haas J, Jung S, Elias W, Zettl UK (2006) Current issues in immunomodulatory treatment of multiple sclerosis--a practical approach. Journal of Neurology 253(Suppl 1):I32\u2013I36","journal-title":"Journal of Neurology"},{"key":"9724_CR205","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1089\/ars.2006.8.2089","volume":"8","author":"J Steiner","year":"2006","unstructured":"Steiner J, Haughey N, Li W, Venkatesan A, Anderson C, Reid R, Malpica T, Pocernich C, Butterfield DA, Nath A (2006) Oxidative stress and therapeutic approaches in HIV dementia. Antioxidants & Redox Signaling 8:2089\u20132100","journal-title":"Antioxidants & Redox Signaling"},{"key":"9724_CR206","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1089\/hum.2009.103","volume":"20","author":"X Su","year":"2009","unstructured":"Su X, Kells AP, Huang EJ, Lee HS, Hadaczek P, Beyer J, Bringas J, Pivirotto P, Penticuff J, Eberling J (2009) Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys. Human Gene Therapy 20:1627\u20131640","journal-title":"Human Gene Therapy"},{"key":"9724_CR207","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/sj.gt.3301868","volume":"10","author":"Y Sun","year":"2003","unstructured":"Sun Y, Jin K, Clark K, Peel A, Mao X, Chang Q, Simon R, Greenberg D (2003) Adeno-associated virus-mediated delivery of BCL-w gene improves outcome after transient focal cerebral ischemia. Gene Therapy 10:115\u2013122","journal-title":"Gene Therapy"},{"key":"9724_CR208","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jconrel.2016.02.003","volume":"231","author":"J-KY Tan","year":"2016","unstructured":"Tan J-KY, Pham B, Zong Y, Perez C, Maris DO, Hemphill A, Miao CH, Matula TJ, Mourad PD, Wei H (2016) Microbubbles and ultrasound increase intraventricular polyplex gene transfer to the brain. Journal of Controlled Release 231:86\u201393","journal-title":"Journal of Controlled Release"},{"key":"9724_CR209","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0022-3999(02)00428-2","volume":"53","author":"S Tekin","year":"2002","unstructured":"Tekin S, Cummings JL (2002) Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. Journal of Psychosomatic Research 53:647\u2013654","journal-title":"Journal of Psychosomatic Research"},{"key":"9724_CR210","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.nbd.2004.07.009","volume":"17","author":"Z-P Teng","year":"2004","unstructured":"Teng Z-P, Chen J, Chau L-Y, Galunic N, Regan RF (2004) Adenoviral transfer of the heme oxygenase-1 gene protects striatal astrocytes from heme-mediated oxidative injury. Neurobiology of Disease 17:179\u2013187","journal-title":"Neurobiology of Disease"},{"key":"9724_CR211","doi-asserted-by":"publisher","first-page":"7482","DOI":"10.1073\/pnas.120474397","volume":"97","author":"CE Thomas","year":"2000","unstructured":"Thomas CE, Schiedner G, Kochanek S, Castro MG, L\u00f6wenstein PR (2000) Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chronic diseases. Proceedings of the National Academy of Sciences 97:7482\u20137487","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"9724_CR212","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/jgm.584","volume":"6","author":"RB Tinsley","year":"2004","unstructured":"Tinsley RB, Vesey MJ, Barati S, Rush RA, Ferguson IA (2004) Improved non-viral transfection of glial and adult neural stem cell lines and of primary astrocytes by combining agents with complementary modes of action. The Journal of Gene Medicine 6:1023\u20131032","journal-title":"The Journal of Gene Medicine"},{"key":"9724_CR213","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.2174\/0929867311320170006","volume":"20","author":"G Tosi","year":"2013","unstructured":"Tosi G, Bortot B, Ruozi B, Dolcetta D, Vandelli M, Forni F, Severini G (2013) Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier. Current Medicinal Chemistry 20:2212\u20132225","journal-title":"Current Medicinal Chemistry"},{"key":"9724_CR214","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/gt.2009.119","volume":"17","author":"C Towne","year":"2010","unstructured":"Towne C, Schneider B, Kieran D, Redmond D, Aebischer P (2010) Efficient transduction of non-human primate motor neurons after intramuscular delivery of recombinant AAV serotype 6. Gene Therapy 17:141\u2013146","journal-title":"Gene Therapy"},{"key":"9724_CR215","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/bit.24750","volume":"110","author":"HM Tuinstra","year":"2013","unstructured":"Tuinstra HM, Ducommun MM, Briley WE, Shea LD (2013) Gene delivery to overcome astrocyte inhibition of axonal growth: an in vitro model of the glial scar. Biotechnology and Bioengineering 110:947\u2013957","journal-title":"Biotechnology and Bioengineering"},{"key":"9724_CR216","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.biomaterials.2011.11.002","volume":"33","author":"HM Tuinstra","year":"2012","unstructured":"Tuinstra HM, Aviles MO, Shin S, Holland SJ, Zelivyanskaya ML, Fast AG, Ko SY, Margul DJ, Bartels AK, Boehler RM (2012) Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury. Biomaterials 33:1618\u20131626","journal-title":"Biomaterials"},{"key":"9724_CR217","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1006\/brcg.2001.1500","volume":"49","author":"HB Uylings","year":"2002","unstructured":"Uylings HB, De Brabander J (2002) Neuronal changes in normal human aging and Alzheimer\u2019s disease. Brain and Cognition 49:268\u2013276","journal-title":"Brain and Cognition"},{"key":"9724_CR218","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11910-010-0104-8","volume":"10","author":"M Van Spronsen","year":"2010","unstructured":"Van Spronsen M, Hoogenraad CC (2010) Synapse pathology in psychiatric and neurologic disease. Current Neurology and Neuroscience Reports 10:207\u2013214","journal-title":"Current Neurology and Neuroscience Reports"},{"key":"9724_CR219","doi-asserted-by":"publisher","first-page":"19599","DOI":"10.1074\/jbc.M114.567644","volume":"289","author":"N Vartak-Sharma","year":"2014","unstructured":"Vartak-Sharma N, Gelman BB, Joshi C, Borgamann K, Ghorpade A (2014) Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-kappaB signaling and excitatory amino acid transporter-2 repression. The Journal of Biological Chemistry 289:19599\u201319612","journal-title":"The Journal of Biological Chemistry"},{"key":"9724_CR220","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fnagi.2015.00124","volume":"7","author":"R Von Bernhardi","year":"2015","unstructured":"Von Bernhardi R, Eugen\u00edn-von Bernhardi L, Eugen\u00edn J (2015) Microglial cell dysregulation in brain aging and neurodegeneration. Frontiers in Aging Neuroscience 7:124","journal-title":"Frontiers in Aging Neuroscience"},{"key":"9724_CR221","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.nbd.2003.08.014","volume":"14","author":"R Von Bernhardi","year":"2003","unstructured":"Von Bernhardi R, Ramirez G, De Ferrari GV, Inestrosa NC (2003) Acetylcholinesterase induces the expression of the beta-amyloid precursor protein in glia and activates glial cells in culture. Neurobiology of Disease 14:447\u2013457","journal-title":"Neurobiology of Disease"},{"key":"9724_CR222","doi-asserted-by":"publisher","first-page":"e65646","DOI":"10.1371\/journal.pone.0065646","volume":"8","author":"G Von Jonquieres","year":"2013","unstructured":"Von Jonquieres G, Mersmann N, Klugmann CB, Harasta AE, Lutz B, Teahan O, Housley GD, Fr\u00f6hlich D, Kr\u00e4mer-Albers E-M, Klugmann M (2013) Glial promoter selectivity following AAV-delivery to the immature brain. PloS One 8:e65646","journal-title":"PloS One"},{"key":"9724_CR223","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","volume":"386","author":"T Vos","year":"2015","unstructured":"Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, Charlson F, Davis A, Degenhardt L, Dicker D (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the global burden of disease study 2013. Lancet 386:743\u2013800","journal-title":"Lancet"},{"key":"9724_CR224","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.tins.2012.11.007","volume":"36","author":"H Wake","year":"2013","unstructured":"Wake H, Moorhouse AJ, Miyamoto A, Nabekura J (2013) Microglia: actively surveying and shaping neuronal circuit structure and function. Trends in Neurosciences 36:209\u2013217","journal-title":"Trends in Neurosciences"},{"key":"9724_CR225","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/sj.gt.3302771","volume":"13","author":"C Wang","year":"2006","unstructured":"Wang C, Wang S (2006) Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter. Gene Therapy 13:1447\u20131456","journal-title":"Gene Therapy"},{"key":"9724_CR226","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/sj.gt.3302011","volume":"10","author":"C Wang","year":"2003","unstructured":"Wang C, Wang C, Clark K, Sferra T (2003a) Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain. Gene Therapy 10:1528\u20131534","journal-title":"Gene Therapy"},{"key":"9724_CR227","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/glia.22743","volume":"63","author":"CY Wang","year":"2015","unstructured":"Wang CY, Yang SH, Tzeng SF (2015) MicroRNA-145 as one negative regulator of astrogliosis. Glia 63:194\u2013205","journal-title":"Glia"},{"key":"9724_CR228","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1517\/17425247.2014.871258","volume":"11","author":"D Wang","year":"2014","unstructured":"Wang D, Zhong L, Nahid MA, Gao G (2014) The potential of adeno-associated viral vectors for gene delivery to muscle tissue. Expert Opinion on Drug Delivery 11:345\u2013364","journal-title":"Expert Opinion on Drug Delivery"},{"key":"9724_CR229","first-page":"342","volume":"86","author":"DD Wang","year":"2008","unstructured":"Wang DD, Bordey A (2008) The astrocyte odyssey. Progress in Neurobiology 86:342\u2013367","journal-title":"Progress in Neurobiology"},{"key":"9724_CR230","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1074\/jbc.M112.407726","volume":"288","author":"J-Q Wang","year":"2013","unstructured":"Wang J-Q, Chen Q, Wang X, Wang Q-C, Wang Y, Cheng H-P, Guo C, Sun Q, Chen Q, Tang T-S (2013) Dysregulation of mitochondrial calcium signaling and superoxide flashes cause mitochondrial genomic DNA damage in Huntington disease. The Journal of Biological Chemistry 288:3070\u20133084","journal-title":"The Journal of Biological Chemistry"},{"key":"9724_CR231","doi-asserted-by":"crossref","unstructured":"Wang L, Lin F, Wang J, Wu J, Han R, Zhu L, Zhang G, DiFiglia M, Qin Z (2012) Truncated N-terminal huntingtin fragment with expanded-polyglutamine (htt552-100Q) suppresses brain-derived neurotrophic factor transcription in astrocytes. Acta Biochim Biophys Sin: gmr125","DOI":"10.1093\/abbs\/gmr125"},{"key":"9724_CR232","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1124\/mol.64.4.833","volume":"64","author":"X Wang","year":"2003","unstructured":"Wang X, Li X, Xu L, Zhan Y, Yaish-Ohad S, Erhardt JA, Barone FC, Feuerstein GZ (2003b) Up-regulation of secretory leukocyte protease inhibitor (SLPI) in the brain after ischemic stroke: adenoviral expression of SLPI protects brain from ischemic injury. Molecular Pharmacology 64:833\u2013840","journal-title":"Molecular Pharmacology"},{"key":"9724_CR233","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1006\/mthe.2002.0584","volume":"5","author":"DJ Watson","year":"2002","unstructured":"Watson DJ, Kobinger GP, Passini MA, Wilson JM, Wolfe JH (2002) Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins. Molecular Therapy 5:528\u2013B221","journal-title":"Molecular Therapy"},{"key":"9724_CR234","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/gt.2011.49","volume":"18","author":"M Weinberg","year":"2011","unstructured":"Weinberg M, Blake B, Samulski RJ, Mccown TJ (2011) The influence of epileptic neuropathology and prior peripheral immunity on CNS transduction by rAAV2 and rAAV5. Gene Therapy 18:961\u2013968","journal-title":"Gene Therapy"},{"key":"9724_CR235","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1093\/hmg\/ddv168","volume":"24","author":"CM Weismann","year":"2015","unstructured":"Weismann CM, Ferreira J, Keeler AM, Su Q, Qui L, Shaffer SA, Xu Z, Gao G, Sena-Esteves M (2015) Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan. Human Molecular Genetics 24:4353\u20134364","journal-title":"Human Molecular Genetics"},{"key":"9724_CR236","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.addr.2011.10.007","volume":"64","author":"HL Wong","year":"2012","unstructured":"Wong HL, XY W, Bendayan R (2012) Nanotechnological advances for the delivery of CNS therapeutics. Advanced Drug Delivery Reviews 64:686\u2013700","journal-title":"Advanced Drug Delivery Reviews"},{"key":"9724_CR237","doi-asserted-by":"publisher","first-page":"a006346","DOI":"10.1101\/cshperspect.a006346","volume":"2","author":"T Wyss-Coray","year":"2012","unstructured":"Wyss-Coray T, Rogers J (2012) Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harbor Perspectives in Medicine 2:a006346","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"9724_CR238","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1089\/hum.2004.15.1243","volume":"15","author":"C-F Xia","year":"2004","unstructured":"Xia C-F, Yin H, Borlongan CV, Chao J, Chao L (2004) Adrenomedullin gene delivery protects against cerebral ischemic injury by promoting astrocyte migration and survival. Human Gene Therapy 15:1243\u20131254","journal-title":"Human Gene Therapy"},{"key":"9724_CR239","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.neuroscience.2010.08.034","volume":"170","author":"Y Xie","year":"2010","unstructured":"Xie Y, Wang T, Sun GY, Ding S (2010) Specific disruption of astrocytic Ca 2+ signaling pathway in vivo by adeno-associated viral transduction. Neuroscience 170:992\u20131003","journal-title":"Neuroscience"},{"key":"9724_CR240","doi-asserted-by":"publisher","first-page":"8167","DOI":"10.1016\/j.biomaterials.2012.07.046","volume":"33","author":"H Xin","year":"2012","unstructured":"Xin H, Sha X, Jiang X, Zhang W, Chen L, Fang X (2012) Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles. Biomaterials 33:8167\u20138176","journal-title":"Biomaterials"},{"key":"9724_CR241","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/mt.2014.68","volume":"22","author":"B Yang","year":"2014","unstructured":"Yang B, Li S, Wang H, Guo Y, Gessler DJ, Cao C, Su Q, Kramer J, Zhong L, Ahmed SS (2014) Global CNS transduction of adult mice by intravenously delivered rAAVrh. 8 and rAAVrh. 10 and nonhuman primates by rAAVrh. 10. Molecular Therapy 22:1299\u20131309","journal-title":"Molecular Therapy"},{"key":"9724_CR242","doi-asserted-by":"publisher","first-page":"e63876","DOI":"10.1371\/journal.pone.0063876","volume":"8","author":"C Yang","year":"2013","unstructured":"Yang C, Yang W-H, Chen S-S, Ma B-F, Li B, Lu T, T-Y Q, Klein RL, Zhao L-R, Duan W-M (2013) Pre-immunization with an intramuscular injection of AAV9-human erythropoietin vectors reduces the vector-mediated transduction following re-administration in rat brain. PloS One 8:e63876","journal-title":"PloS One"},{"key":"9724_CR243","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/gt.2014.82","volume":"21","author":"D Young","year":"2014","unstructured":"Young D, Fong DM, Lawlor PA, Wu A, Mouravlev A, McRae M, Glass M, Dragunow M, During MJ (2014) Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy. Gene Therapy 21:1029\u20131040","journal-title":"Gene Therapy"},{"key":"9724_CR244","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.neuroscience.2014.10.026","volume":"284","author":"D Yurek","year":"2015","unstructured":"Yurek D, Hasselrot U, Cass W, Sesenoglu-Laird O, Padegimas L, Cooper M (2015) Age and lesion-induced increases of GDNF transgene expression in brain following intracerebral injections of DNA nanoparticles. Neuroscience 284:500\u2013512","journal-title":"Neuroscience"},{"key":"9724_CR245","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/mt.2009.2","volume":"17","author":"DM Yurek","year":"2009","unstructured":"Yurek DM, Fletcher AM, Smith GM, Seroogy KB, Ziady AG, Molter J, Kowalczyk TH, Padegimas L, Cooper MJ (2009) Long-term transgene expression in the central nervous system using DNA nanoparticles. Molecular Therapy 17:641\u2013650","journal-title":"Molecular Therapy"},{"key":"9724_CR246","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1038\/mt.2011.98","volume":"19","author":"H Zhang","year":"2011","unstructured":"Zhang H, Yang B, Mu X, Ahmed SS, Su Q, He R, Wang H, Mueller C, Sena-Esteves M, Brown R (2011) Several rAAV vectors efficiently cross the blood\u2013brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system. Molecular Therapy 19:1440\u20131448","journal-title":"Molecular Therapy"},{"key":"9724_CR247","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1089\/104303404322959498","volume":"15","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Schlachetzki F, Zhang Y-F, Boado RJ, Pardridge WM (2004) Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter. Human Gene Therapy 15:339\u2013350","journal-title":"Human Gene Therapy"},{"key":"9724_CR248","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/glia.10195","volume":"42","author":"C Zhao","year":"2003","unstructured":"Zhao C, Strappe PM, Lever AM, Franklin RJ (2003) Lentiviral vectors for gene delivery to normal and demyelinated white matter. Glia 42:59\u201367","journal-title":"Glia"},{"key":"9724_CR249","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jneuroim.2008.06.015","volume":"200","author":"JC Zheng","year":"2008","unstructured":"Zheng JC, Huang Y, Tang K, Cui M, Niemann D, Lopez A, Morgello S, Chen S (2008) HIV-1-infected and\/or immune-activated macrophages regulate astrocyte CXCL8 production through IL-1\u03b2 and TNF-\u03b1: involvement of mitogen-activated protein kinases and protein kinase R. Journal of Neuroimmunology 200:100\u2013110","journal-title":"Journal of Neuroimmunology"},{"key":"9724_CR250","first-page":"716859","volume":"2011","author":"A Zinger","year":"2011","unstructured":"Zinger A, Barcia C, Herrero MT, Guillemin GJ (2011) The involvement of neuroinflammation and kynurenine pathway in Parkinson\u2019s disease. Parkinson\u2019s Disease 2011:716859","journal-title":"Parkinson\u2019s Disease"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-016-9724-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-016-9724-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-016-9724-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T17:23:02Z","timestamp":1684862582000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-016-9724-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,3]]},"references-count":250,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["9724"],"URL":"https:\/\/doi.org\/10.1007\/s11481-016-9724-3","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,3]]},"assertion":[{"value":"29 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest associated to the presented work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}